Campylobacter and antimicrobial resistance in dogs and humans: "One health" in practice

Vet Ital. 2019 Sep 30;55(3):203-220. doi: 10.12834/VetIt.1161.6413.3.

Abstract

Increasing antimicrobial resistance in both medicine and agriculture is recognised as a major emerging public health concern. Since 2005, campylobacteriosis has been the most zoonotic disease reported in humans in the European Union. Human infections due to Campylobacter spp. primarily comes from food. However, the human-animal interface is a potential space for the bidirectional movement of zoonotic agents, including antimicrobial resistant strains. Dogs have been identified as carriers of the Campylobacter species and their role as a source of infection for humans has been demonstrated. Furthermore, dogs may play an important role as a reservoir of resistant bacteria or resistance genes. Human beings may also be a reservoir of Campylobacter spp. for their pets. This review analyses the current literature related to the risk of Campylobacter antimicrobial resistance at the dog-human interface.

Keywords: Antimicrobial resistance; Campylobacter; Dogs; Resistance genes.

Publication types

  • Review

MeSH terms

  • Animals
  • Anti-Bacterial Agents / pharmacology*
  • Campylobacter / drug effects*
  • Campylobacter Infections / drug therapy
  • Campylobacter Infections / microbiology
  • Campylobacter Infections / veterinary*
  • Dog Diseases / drug therapy*
  • Dog Diseases / microbiology
  • Dogs
  • Drug Resistance, Bacterial*
  • Humans
  • One Health
  • Risk Assessment

Substances

  • Anti-Bacterial Agents